Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches-Reference-Cited by-同舟云学术

Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches

Published:2017-09-15 Issue:12 Volume:193 Page:1068-1069
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Moustakis Christos^ORCID,Blanck Oliver,Ebrahimi Fatemeh,ka heng Chan Mark,Ernst Iris,Krieger Thomas,Duma Marciana-Nona,Oechsner Markus,Ganswindt Ute,Heinz Christian,Alheit Horst,Blank Hilbert,Nestle Ursula,Wiehle Rolf,Kornhuber Christine,Ostheimer Christian,Petersen Cordula,Pollul Gerhard,Baus Wolfgang,Altenstein Georg,Beckers Eric,Jurianz Katrin,Sterzing Florian,Kretschmer Matthias,Seegenschmiedt Heinrich,Maass Torsten,Droege Stefan,Wolf Ulrich,Schoeffler Juergen,Haverkamp Uwe,Eich Hans,Guckenberger Matthias

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00066-017-1216-8/fulltext.html

Reference10 articles.

1. Giglioli FR, Strigari L, Ragona R et al (2016) Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies. Phys Med 32(4):600–606

2. Moustakis C, Blanck O, Tazehmahalleh FE et al (2017) Planning benchmark study for SBRT of early stage NSCLC results of the DEGRO working group Stereotactic Radiotherapy. Strahlenther Onkol. https://doi.org/10.1007/s00066-017-1151-8

3. Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33

4. Guckenberger M, Klement RJ, Allgäuer M et al (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118(3):485–491

5. Katoh N, Soda I, Tamamura H et al (2017) Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system. Radiat Oncol 12(1):3. https://doi.org/10.1186/s13014-016-0742-3

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Radiotherapy for Critically Located Pancreatic and Biliary Targets: A Review on Simultaneous Integrated Protection and Other Dose-Painting Strategies to Minimize Dose to Critical Organs at Risk;Radiation;2023-05-16

2. Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study;Radiotherapy and Oncology;2023-05

3. Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives;International Journal of Radiation Oncology*Biology*Physics;2020-02

4. Strahlentherapie bei Patientinnen mit oligometastasiertem Mammakarzinom;Der Gynäkologe;2019-08-30

5. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams;Strahlentherapie und Onkologie;2019-01-16